Concepedia
Statistics
Publications
5
Citations
529
H-Index
Active since
2007
Affiliations
Memorial Sloan Kettering Cancer Center(Current)
The University of Texas MD Anderson Cancer Center
University of California, Los Angeles
Harvard University Press
National Cancer Institute
H. I. Robins is an author at Memorial Sloan Kettering Cancer Center specializing in oncology, brain tumors, and neuro-oncology.
Publications per year
2007–2014
A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy
Jeffery J. Raizer, L. E. Abrey, Andrew B. Lassman et al. · Neuro-Oncology · 2009 · 298 citations · Full text
Medicine, Oncology, Pharmacology +17
Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?
Jennifer Clarke, M. M. Ennis, W. K. Alfred Yung et al. · Neuro-Oncology · 2011 · 118 citations · Full text
Medicine, Oncology, Surgery +17
Initial treatment patterns over time for anaplastic oligodendroglial tumors
Katherine S. Panageas, Fábio M. Iwamoto, Timothy F. Cloughesy et al. · Neuro-Oncology · 2012 · 57 citations · Full text
Medicine, Oncology, Radiation Oncology +10
Phase I study of erlotinib and CCI-779 (temsirolimus) for patients with recurrent malignant gliomas (MG) (NABTC 04–02)
H. I. Robins, Patrick Y. Wen, Shi Chang et al. · Journal of Clinical Oncology · 2007 · 42 citations
Recursive partitioning analysis of prognostic variables in newly diagnosed anaplastic oligodendroglial tumors
Katherine S. Panageas, Anne S. Reiner, Fábio M. Iwamoto et al. · Neuro-Oncology · 2014 · 14 citations · Full text
Medicine, Neurology, Oncology +17
1–5 of 5